Validating a novel target and informing trial design for a first-in-class therapeutic

A new era of biopharma R&D: The TechBio revolution—realities and the next frontier

Join Tempus and Recursion leaders to explore their strategic TechBio partnership. Learn how they use AI and supercomputing with petabytes of data to accelerate drug discovery and development. See the impact on biopharma R&D's future.

Watch replay

Guiding indication expansion with multimodal real-world data

Discover how a biopharma company used Tempus’ multimodal real-world data to guide its indication expansion strategy. See how our analysis of biomarker prevalence helped them identify new opportunities, prioritize R&D, and inform future trial design.

Read more

Precision Medicine 2.0: The operating system for oncology R&D

This white paper addresses the persistent challenges in oncology R&D, demonstrating how precision medicine has evolved into a new paradigm built on systems-level understanding and AI-driven insights. Download for a comprehensive overview of Precision Medicine 2.0, its core scientific pillars, enabling technologies, and how R&D organizations can leverage this integrated approach to optimize their cancer research.

Read more